MSD Vietnam’s empowering workplace
August 12, 2024 | 16:43
Pharma company MSD Vietnam has been recognised at the HR Asia Awards 2024 for its exceptional human resource policies.
The legal adaption measures expected from pharma groups
December 01, 2022 | 13:00
Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
Pharma firms reveal stellar 2021 business
March 18, 2022 | 18:00
International pharma giants Novartis, Sanofi, Pfizer, and MSD had solid business performances during 2021, with a bumper year forecast for the whole of this year driven by vaccines and treatment pills.
Wake-up call for pharma firms with poor practices
February 27, 2020 | 15:00
The new sanctions for drug quality violations drafted by the Ministry of Health are expected to come out soon, threatening manufacturers and traders to have their operations suspended and business certificates revoked should they fail to comply with set standards.
Pharma firms look to future
March 29, 2019 | 11:00
With expected fierce rivalry as a result of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership, domestic Vietnamese pharmaceutical businesses are increasingly investing big in technological innovations that help them stay competitive in a lucrative market.
Pharma firms weigh up FOL removal
October 04, 2018 | 10:00
After years of takeover fears, more of Vietnam’s leading pharmaceutical firms now ponder a historic change of heart by scrapping foreign ownership limits with a view to the international market, then opening vast distribution business opportunities for new players. Bich Thuy reports.
Mobile Version